Works by Horan, Christopher


Results: 7
    1

    Phase 1 study of intraventricular <sup>131</sup>I-omburtamab targeting B7H3 (CD276)-expressing CNS malignancies.

    Published in:
    Journal of Hematology & Oncology, 2022, v. 15, n. 1, p. 1, doi. 10.1186/s13045-022-01383-4
    By:
    • Kramer, Kim;
    • Pandit-Taskar, Neeta;
    • Kushner, Brian H.;
    • Zanzonico, Pat;
    • Humm, John L.;
    • Tomlinson, Ursula;
    • Donzelli, Maria;
    • Wolden, Suzanne L.;
    • Haque, Sophia;
    • Dunkel, Ira;
    • Souweidane, Mark M.;
    • Greenfield, Jeffrey P.;
    • Tickoo, Satish;
    • Lewis, Jason S.;
    • Lyashchenko, Serge K.;
    • Carrasquillo, Jorge A.;
    • Chu, Bae;
    • Horan, Christopher;
    • Larson, Steven M.;
    • Cheung, Nai-Kong V.
    Publication type:
    Article
    2
    3
    4
    5

    Theranostic Intratumoral Convection-Enhanced Delivery of <sup>124</sup>I-Omburtamab in Patients with Diffuse Intrinsic Pontine Glioma: Pharmacokinetics and Lesion Dosimetry.

    Published in:
    Journal of Nuclear Medicine, 2024, v. 65, n. 9, p. 1364, doi. 10.2967/jnumed.123.266365
    By:
    • Pandit-Taskar, Neeta;
    • Zanzonico, Pat B.;
    • Grkovski, Milan;
    • Donzelli, Maria;
    • Vietri, Scott M.;
    • Horan, Christopher;
    • Serencsits, Brian;
    • Prasad, Kavya;
    • Lyashchenko, Serge;
    • Kramer, Kim;
    • Dunkel, Ira J.;
    • Souweidane, Mark M.
    Publication type:
    Article
    6
    7